Bullbearadvisor 
RadNet, Inc. (NASDAQ: RDNT) is a leading provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. Founded in 1980 and headquartered in Los Angeles, California, the company operates a network of imaging centers offering a wide range of services, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. These facilities equip physicians with advanced imaging capabilities to aid in the diagnosis and treatment of various diseases and disorders, aiming to reduce the need for invasive procedures. Additionally, RadNet has an Artificial Intelligence segment that develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes, focusing on areas such as brain, breast, prostate, and pulmonary diagnostics. finance.yahoo.com morningstar.com
Over the past 52 weeks, RadNet's stock has reached a high of $93.65 and a low of $36.47. finance.yahoo.com
Analyst sentiment towards RadNet is notably positive. According to ChartMill, 12 analysts have provided ratings, with 85% recommending a "Buy." chartmill.com
Similarly, TipRanks reports an average price target of $81.75, suggesting a potential upside of approximately 37.46%. tipranks.com
Subscribe to our API. See Strong Buy and Sell Signals the Day after They Occur!
